Loading...
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
There is currently a lack of biological tools to study the replication cycle and pathogenesis of SARS-CoV-2, the etiological agent of COVID-19. Repurposing the existing tools, including antibodies of SARS-CoV, is an effective way to accelerate the development of therapeutics for COVID-19. Here, we e...
Na minha lista:
| Udgivet i: | bioRxiv |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cold Spring Harbor Laboratory
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7402058/ https://ncbi.nlm.nih.gov/pubmed/32766589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.07.30.229377 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|